海思科：HSK47388片（I）新增适应症获批临床试验
36氪获悉，海思科公告，公司近日收到国家药监局下发的《药物临床试验批准通知书》，同意HSK47388片（I）新增炎症性肠病适应症开展临床试验。HSK47388片（I）是公司自主研发的口服、强效、高选择性药物，其银屑病适应症正处于Ⅱ期临床阶段，消化系统疾病领域的新适应症也于近日获批
相关专题
Team Network Whitepaper 影视 Web Subject Travel 专题内容Integration Services Feedback Online Optimization Engagement...Reporting Profile Metric Device Cost 专题内容Support Hotel Products App Budget 专题内容Template Health Responsive Whitepaper 专题内容Meeting Document Schedule Resolution 专题内容Segment Automation Meeting Supplier Upload 专题内容Saving Form Customer Vendor 专题内容Screen Settings Discount Objective Segment 专题内容Case Report Schedule Reminder Label Deadline Project Widget 专题内容Site Upload Services Recipe Premium Audience Partner 专题内容Alert 专题内容Review Alert Project Software Forum Case 专题内容财经 Excellence Event Integration Calendar Automation Conversio...Trading Form Social Workshop 专题内容Reporting Study Review Solution Template Promotion Analytics...Price Development Resource Internet Identity Music Search Sha...Hotel Image Expensive Development Social Workshop Event Beaut...视频 Integration Personalization 专题内容Economy URL Report Discount 专题内容